# Delcath Systems share price today (Delcath Systems, Inc., DCTH)

> Delcath Systems, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. DCTH · Healthcare · Medical Devices · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/dcth

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $14.40 (+46.5% in a year)
- P/E: 979.6×, over 1 year
- Revenue (Jun 2026): $29.1 M (+20.6% on a year ago)
- Profit (Jun 2026): $2.7 M (−1.1% on a year ago)
- Operating margin: 8.2% (−2.5 points on a year ago)
- ROE: 2%, FY25

Biggest thing to watch: margins are the best this company has ever reported. Every ratio looks better at a record, so the story depends on margins staying high. ## What is the Delcath Systems share price today? Delcath Systems, Inc.'s share price was $14.40 at the close on 3 November 2026. That is 16.3% above its average price over the last 200 trading days. In the last 52 weeks it traded between $9 and $17, and at that close it sat 68% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 1 week running. Over the last 1 year the share price moved +27% while the S&P 500 moved +21%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 30 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Delcath Systems pay? Delcath Systems, Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Delcath Systems on? Delcath Systems is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Delcath Systems profitable? Delcath Systems, Inc. earned $2.7 M of net profit in the Jun 2026 quarter, −1.1% on the same quarter a year earlier. Full-year FY25 profit was $2.7 M. That is 9.2% of the quarter's revenue. The same quarter a year earlier earned $2.7 M. 7 of the last 12 reported quarters were loss-making. Why profit moved: revenue changed +20.6% on a year earlier and the margin moved −2.5 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed −85.6% and revenue +41.9%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Delcath Systems make, and is it growing? Delcath Systems, Inc. reported $29.1 M of revenue in the Jun 2026 quarter, +20.6% on the same quarter a year earlier. That is the 10th quarter in a row with growth on the year before. Over 4 years it has grown 121.3% a year on average. The last full year, FY25, came in at $85.2 M. The last four reported quarters add to $95.4 M. FY25 revenue was $85.2 M, +129.1% on the year before. Recent pace: the last four quarters grew +41.9% on average, against 121.3% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +35.8%, against +183.4% a year over the last 8 quarters (rolling over). ## How much of every $100 of sales does Delcath Systems keep? Delcath Systems, Inc.'s operating margin was 8.2% in the Jun 2026 quarter, 2.5 percentage points lower than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 5 years it has been between −1,849.0% and 0.8%. The latest quarter is above every full year in that period. Across 5 years it has been between −1,849.0% and 0.8%, and FY25's 0.8% is the highest of them. Why the margin moved: operating margin changed −2.5 percentage points on the year while gross margin changed +3.5 points. So the drop came mostly from the gross margin, which means input costs and prices charged. When margins are at a record, every ratio built on profit looks better than usual, so watch whether they hold. ## Is Delcath Systems' profit turning into cash? Delcath Systems, Inc.'s cash-flow history is too short to judge how much of its profit turns into cash. In FY25 it brought in $22.5 M of operating cash against $2.7 M of profit. After $1.5 M of spending on assets, $21.0 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Delcath Systems' cash go? Delcath Systems, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $2.2 M on assets over the last 3 years. Averaged over those years that is 0.8% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $2.2 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Delcath Systems' P/E ratio, and how does it compare with its own history? Delcath Systems, Inc.'s P/E is 979.6×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth. In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple. ## Is the Delcath Systems business getting better or worse? Delcath Systems, Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Delcath Systems earn on its capital? Delcath Systems, Inc. earned a ROE of 2% in FY25. That is up from a low of −224% in FY23. Its return on capital used (ROIC) is left out: on sales this small it reads −3,495%, a number that says nothing useful about the business. It comes from a 3.2% net margin and 0.69× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 3.2% net margin × 0.69× asset turnover × 1.11× leverage (assets divided by equity) ≈ 2.5% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. ## Does Delcath Systems have too much debt? Delcath Systems, Inc. has total debt of $2.5 M against shareholder equity of $121 M as of Jun 2026, so its debt is 0.02× its equity, which is very little. Year by year, that ratio went from 1.41 in FY21 to 0.01 in FY25. So the returns on this page come from the business, not from borrowed money. ## What is the Delcath Systems shareholding pattern? 7.4% of Delcath Systems, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 5.6 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Delcath Systems from balance-sheet trouble? For Delcath Systems, Inc., the Z-score is 10.04. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 10.04 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Delcath Systems rank in its industry? There is no score against its industry: Delcath Systems, Inc. is not among the largest members shown in this industry comparison for Medical Devices. The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown. ## Which companies is Delcath Systems compared with? No sector comparison is shown here, not among the largest members shown in this industry comparison. ## Which companies are close to Delcath Systems in size? Delcath Systems is the 53rd largest of 75 Medical Devices companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Pacific Biosciences of California, Inc., Tactile Systems Technology, Inc. and Sight Sciences, Inc. Just below it: AVITA Medical, Inc., Cerus Corporation and Senseonics Holdings, Inc. ### Medical Devices companies close in size

1. [Pacific Biosciences of California, Inc.](https://www.sectoralpha.in/us/stocks/pacb) $758 million
2. [Tactile Systems Technology, Inc.](https://www.sectoralpha.in/us/stocks/tcmd) $561 million
3. [Sight Sciences, Inc.](https://www.sectoralpha.in/us/stocks/sght) $519 million
4. Delcath Systems, Inc. $500 million
5. [AVITA Medical, Inc.](https://www.sectoralpha.in/us/stocks/rcel) $474 million
6. [Cerus Corporation](https://www.sectoralpha.in/us/stocks/cers) $472 million
7. [Senseonics Holdings, Inc.](https://www.sectoralpha.in/us/stocks/sens) $468 million

[All 75 Medical Devices companies, largest first](https://www.sectoralpha.in/us/sectors/medical-devices#all-companies)

### Companies close in size in other industries

1. [Aquestive Therapeutics, Inc.](https://www.sectoralpha.in/us/stocks/aqst) $488 million · Drug Manufacturers - Specialty & Generic
2. [Core Laboratories Inc.](https://www.sectoralpha.in/us/stocks/clb) $488 million · Oil & Gas Equipment & Services
3. Delcath Systems, Inc. $487 million
4. [One Liberty Properties, Inc.](https://www.sectoralpha.in/us/stocks/olp) $487 million · REIT - Diversified
5. [Evolent Health, Inc.](https://www.sectoralpha.in/us/stocks/evh) $486 million · Health Information Services

## What else do people ask about Delcath Systems? ### What were Delcath Systems's latest quarterly results? Delcath Systems, Inc. reported revenue of $29.1 M and net profit of $2.7 M for the Jun 2026 quarter. Revenue rose 20.6% and profit fell 1.1% compared with a year earlier. Earnings per share were $0.07. The operating margin was 8.2%, 2.5 percentage points lower than a year earlier (as of 3 November 2026). ### What is Delcath Systems's market cap? Delcath Systems, Inc.'s market capitalisation is $500 M at a stock price of $14.40. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Delcath Systems performing? Delcath Systems, Inc.'s latest readings are below. In its latest quarter, revenue rose 20.6% and profit fell 1.1% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 1 week running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Delcath Systems's stock price go up? This page does not forecast Delcath Systems, Inc.'s stock price. What it shows instead: the stock price is $14.40. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Where is Delcath Systems in its business cycle? Delcath Systems, Inc.'s FY25 operating margin was 0.8%, against a 5-year range of −1,849.0% to 0.8%: the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high. The latest quarter was 8.2%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Delcath Systems story? Biggest thing to watch: margins are the best this company has ever reported. Every ratio looks better at a record, so the story depends on margins staying high. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Delcath Systems a stock worth studying right now? What the numbers show: Delcath Systems, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.